1. Epigenetics Drugs and Diagnostic Technologies Market - Global Industry Analysis, Size, Share, Growth,
Trends and Forecast 2012 - 2018
The research report on the epigenetics drugs and diagnostic technologies market provides detailed analysis of
the global market and helps in understanding the driving forces for the growth of these technologies. The
report also provides analysis of the drugs market by the mechanism of its action namely, DNMT inhibitors and
HDAC inhibitors. The report also discusses the diagnostic technologies market by types which include DNA
methylation and ChIP (Chromatin Immunoprecipitation) technology. Market size estimates and forecasts for
the period 2010 to 2018 has been given for each segment and sub-segment, in terms of USD million, using
2010 as the base year.
The market has also been segmented geographically into four regions namely North America, Europe,
Asia-Pacific, and Rest of the World (RoW). Market size and forecast has been provided for each of these
regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the
epigenetics market and future opportunities are provided in the report.
Competitive landscape and end user analysis for the product types is highlighted and the market players are
profiled with attributes such as company overview, financial overview, business strategies, product portfolio
and recent developments. Market shares of the key players for 2011 are provided, and recommendations to
accentuate market shares and ensure sustainability are also put forward in this report. Key market player
profiles in this report include Celgene Corporation, Eisai Pharmaceuticals, Pharmacyclics Inc., Merck & Co.
Inc. and others.   The global epigenetics drugs and diagnostic technologies market is segmented into
the following categories:
Epigenetics Drugs Market, by Mechanism of Action DNMT Inhibitors Azacitidine (Vidaza) Decitabine
(Dacogen HDAC Inhibitors Vorinostat (Zolinza Romidepsin (Istodax)
Epigenetics Diagnostic Technologies Market, by Types DNA Methylation Chromatin Immunoprecipitation
(ChIP) Technology
Epigenetics Technologies Market, by Geography North America Europe Asia-Pacific
table Of Content
chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
chapter 2 Executive Summary
2.1 Market Snapshot: Global Epigenetics Market (2011 & 2018)
2.2 Global Epigenetics Market, By Segments, 2011 (usd Million)
chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Increase In Demand For The Treatment Of Oncology And Non-oncology Conditions
Epigenetics Drugs and Diagnostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018

2. 3.2.2 Huge Amounts Of Investment
3.2.3 Advances In Screening Tools
3.2.4 Impact Analysis Of Market Drivers
3.3 Market Restraints
3.3.1 Genericization Of Major Drugs
3.3.2 Impact Analysis Of Market Restraints
3.4 Market Opportunities
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power Of Buyers
3.5.2 Bargaining Power Of Suppliers
3.5.3 Threat Of New Entrants
3.5.4 Threat Of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis
chapter 4 Epigenetics Drugs Market, By Mechanism Of Action
4.1 Overview
4.1.1 Global Epigenetic Drugs Market, By Mechanism Of Action, 2010 – 2018 (usd Million)
4.1.2 Histone Deacetylase (hdac) Inhibitors
4.1.3 Global Hdac Inhibitors Market, By Drugs, 2010 – 2018 (usd Million)
4.1.3.1 Vorinostat
4.1.3.2 Global Vorinostat Market, By Types 2010 – 2018 (usd Million)
4.1.3.3 Romidepsin
4.1.3.4 Global Romidepsin Market, By Types 2010 – 2018 (usd Million)
4.1.4 Dna Methyltransferase (dnmt) Inhibitors
4.1.5 Global Dnmt Inhibitors Market, By Drugs, 2010–2018 (usd Million)
4.1.5.1 Decitabine
4.1.5.2 Global Decitabine Market, By Types 2010 – 2018 (usd Million)
4.1.5.3 Azacitidine
4.1.5.4 Global Azacitidine Market, By Types 2010 – 2018 (usd Million)
4.1.6 Pipeline Drugs
4.1.6.1 Mocetinostat
4.1.6.2 Abexinostat
4.1.6.3 Resminostat
4.1.6.4 Rocilinostat
4.1.6.5 Chr 3996
4.1.6.6 Evp 0334
4.1.6.7 Panobinostat
4.1.6.8 Belinostat
4.1.6.9 Entinostat
4.1.6.10 Valproic Acid
4.1.6.11 Histone Methyltransferase (hmt) Inhibitors
chapter 5 Epigenetics Diagnostic Technology Market, By Types
5.1 Overview
Epigenetics Drugs and Diagnostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018

3. 5.1.1 Global Epigenetic Diagnostic Technologies Market, By Types, 2010 – 2018 (usd Million)
5.2 Dna Methylation
5.2.1.1 Global Dna Methylation Technology Market, By Types 2010 – 2018 (usd Million)
5.2.2 Chromatin Immunoprecipitation (chip)
5.2.2.1 Global Chromatin Immunoprecipitation (chip) Technology Market, By Types 2010 – 2018
(usd Million)
chapter 6 Global Epigenetics Technologies Market, By Geography
6.1 Overview
6.1.1 Global Epigenetics Technologies Market, By Geography, 2010–2018 (usd Million)
6.2 Comparative Analysis: Epigenetic Technologies Market, By Geography, 2011 & 2018 (value %)
6.3 North America
6.3.1 North America Epigenetics Technologies Market, By Geography, 2010 – 2018 (usd Million)
6.4 Europe
6.4.1 Europe Epigenetics Technologies Market, By Geography, 2010 – 2018 (usd Million)
6.5 Asia-pacific
6.5.1 Asia-pacific Epigenetics Technologies Market, By Geography, 2010 – 2018 (usd Million)
6.6 Rest Of The World
6.6.1 Row Epigenetics Technologies Market, By Geography, 2010 – 2018 (usd Million)
chapter 7 Competitive Landscape
7.1 Market Share Analysis, By Key Players (%)
chapter 8 Recommendations
8.1 Market Strategy For Success
8.2 Barriers To Be Considered
chapter 9 Company Profiles
9.1 4sc Ag
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Overview
9.1.4 Business Strategy
9.1.5 Recent Developments
9.2 Acetylon Pharmaceuticals, Inc.
9.2.1 Company Overview
9.2.2 Financial Overview
9.2.3 Product Overview
9.2.4 Business Strategy
9.2.5 Recent Developments
9.3 Astex Pharmaceuticals Inc.
9.3.1 Company Overview
9.3.2 Financial Overview
Epigenetics Drugs and Diagnostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018

4. 9.3.3 Product Portfolio
9.3.4 Business Strategy
9.3.5 Recent Developments
9.4 Cellcentric Ltd.
9.4.1 Company Overview
9.4.2 Financial Overview
9.4.3 Product Portfolio
9.4.4 Business Strategy
9.4.5 Recent Developments
9.5 Celleron Therapeutics Ltd.
9.5.1 Company Overview
9.5.2 Financial Overview
9.5.3 Product Portfolio
9.5.4 Business Strategy
9.6 Celgene Corporation
9.6.1 Business Overview
9.6.2 Financial Overview
9.6.3 Business Strategy
9.6.4 Recent Developments
9.7 Chroma Therapeutics Ltd.
9.7.1 Company Overview
9.7.2 Financial Overview
9.7.3 Product Overview
9.7.4 Business Strategy
9.7.5 Recent Developments
9.8 Epigentek Group Inc.
9.8.1 Business Overview
9.8.2 Financial Overview
9.8.3 Business Strategy
9.8.4 Recent Developments
9.9 Eisai Co. Ltd.
9.9.1 Company Overview
9.9.2 Financial Overview
9.9.3 Product Portfolio
9.9.4 Business Strategy
9.9.5 Recent Developments
9.10 Envivo Pharmaceuticals Inc.
9.10.1 Company Overview
9.10.2 Financial Overview
9.10.3 Product Portfolio
9.10.4 Business Strategy
9.11 Epizyme, Inc.
9.11.1 Company Overview
9.11.2 Financial Overview
9.11.3 Product Portfolio
9.11.4 Business Strategy
9.11.5 Recent Developments
Epigenetics Drugs and Diagnostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018

5. 9.12 Illumina Inc.
9.12.1 Company Overview
9.12.2 Financial Overview
9.12.3 Product Portfolio
9.12.4 Business Strategies
9.12.5 Recent Developments
9.13 Mdxhealth
9.13.1 Company Overview
9.13.2 Financial Overview
9.13.3 Product Portfolio
9.13.4 Business Strategy
9.13.5 Recent Developments
9.14 Merck & Company Inc.
9.14.1 Company Overview
9.14.2 Financial Overview
9.14.3 Product Portfolio
9.14.4 Business Strategy
9.15 Novartis International Ag
9.15.1 Company Overview
9.15.2 Financial Overview
9.15.3 Product Portfolio
9.15.4 Business Strategy
9.15.5 Mergers And Acquisitions
9.16 Oncolys Biopharma Inc.
9.16.1 Company Overview
9.16.2 Financial Overview
9.16.3 Product Portfolio
9.16.4 Business Strategy
9.17 Pharmacyclics, Inc.
9.17.1 Company Overview
9.17.2 Financial Overview
9.17.3 Product Portfolio
9.17.4 Business Strategy
9.17.5 Recent Developments
9.18 Promega Corporation
9.18.1 Company Overview
9.18.2 Financial Overview
9.18.3 Product Portfolio
9.18.4 Business Strategy
9.18.5 Recent Developments
9.19 Repligen Corporation
9.19.1 Company Overview
9.19.2 Financial Overview
9.19.3 Product Portfolio
9.19.4 Business Strategy
9.19.5 Recent Developments
9.20 Spectrum Pharmaceuticals
Epigenetics Drugs and Diagnostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018

6. 9.20.1 Company Overview
9.20.2 Financial Overview
9.20.3 Product Portfolio
9.20.4 Business Strategy
9.20.5 Recent Developments
9.21 Syndax Pharmaceuticals, Inc.
9.21.1 Company Overview
9.21.2 Financial Overview
9.21.3 Product Portfolio
9.21.4 Business Strategy
9.21.5 Recent Developments
9.22 Topotarget A/s
9.22.1 Company Overview
9.22.2 Financial Overview
9.22.3 Product Portfolio
9.22.4 Business Strategy
9.22.5 Recent Developments
9.23 Valirx Plc
9.23.1 Company Profile
9.23.2 Financial Overview
9.23.3 Product Portfolio And Technology
9.23.4 Business Strategy
9.23.5 Recent Developments
Market Research Report(http://www.marketresearchreports.biz/) Marketresearchreports.biz is the most
comprehensive collection of market research reports. Marketresearchreports.biz services are especially
designed to save time and money of our clients. We are a one stop solution for all your research needs, our
main offerings are syndicated research reports, custom research, subscription access and consulting services.
We serve all sizes and types of companies spanning across various industries.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.com
Website: www.marketresearchreports.biz
Epigenetics Drugs and Diagnostic Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018